1. Home
  2. HLX vs ABCL Comparison

HLX vs ABCL Comparison

Compare HLX & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Helix Energy Solutions Group Inc.

HLX

Helix Energy Solutions Group Inc.

HOLD

Current Price

$7.11

Market Cap

941.3M

Sector

Energy

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$4.10

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HLX
ABCL
Founded
1979
2012
Country
United States
Canada
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
941.3M
1.1B
IPO Year
1997
2020

Fundamental Metrics

Financial Performance
Metric
HLX
ABCL
Price
$7.11
$4.10
Analyst Decision
Strong Buy
Buy
Analyst Count
2
5
Target Price
$10.50
$7.75
AVG Volume (30 Days)
1.5M
4.5M
Earning Date
02-23-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
497.36
N/A
EPS
0.28
N/A
Revenue
$1,312,445,000.00
$35,325,000.00
Revenue This Year
N/A
$25.45
Revenue Next Year
$4.96
$10.07
P/E Ratio
$25.10
N/A
Revenue Growth
N/A
7.17
52 Week Low
$5.52
$1.89
52 Week High
$9.18
$6.52

Technical Indicators

Market Signals
Indicator
HLX
ABCL
Relative Strength Index (RSI) 57.61 55.48
Support Level $6.15 $4.08
Resistance Level $7.47 $4.66
Average True Range (ATR) 0.21 0.27
MACD 0.07 0.06
Stochastic Oscillator 72.28 57.58

Price Performance

Historical Comparison
HLX
ABCL

About HLX Helix Energy Solutions Group Inc.

Helix Energy Solutions Group Inc is an offshore energy services company. It provides specialty services to the offshore energy industry, with an emphasis on well intervention and robotics operations. Helix provides services in deep water in the Gulf of Mexico, Brazil, the North Sea, Asia Pacific and West Africa regions. It has four segments: Well Intervention, Robotics, Shallow Water Abandonment and Production Facilities. the Well Intervention segment includes vessels and equipment used to perform well intervention services in the Gulf of Mexico, the North Sea and Brazil. It derives the majority of its revenue from the U.S.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: